Global Prenatal Testing Market Expected to Grow with a CAGR of 9.59% During the Forecast Period, 2019-2024 -

DUBLIN--()--The "Prenatal Testing Market - Forecasts from 2019 to 2024" report has been added to's offering.

Global prenatal testing market is projected to grow at a CAGR of 9.59% to reach US$6.191 billion by 2024, from US$3.574 billion in 2018.

Prenatal tests are procedures that make sure that the mother and the fetus are healthy. Common prenatal testing includes ultrasound tests, amniocentesis, and chorionic villi sampling (CVS) tests. Growing healthcare expenditure, rising stress conditions due to the adoption of unhealthy living conditions are driving the growth of the global prenatal testing market in the forecast period. Currently, the focus is on non-invasive prenatal testing.

The market is fueled by the surge in the number of late pregnancies coupled with the rising demand of the non-invasive procedures for early diagnosis of chromosomal disorders to help in the proper management of disease during the initial period of the gestation. An increase in healthcare investments and growing awareness regarding prenatal testing will provide ample opportunities for growth for the market players during the given forecast period.

The Global Prenatal Testing Market - Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by techniques, indication, end-users, and geography.

Major players in the prenatal testing market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in prenatal testing market.

Key Topics Covered:


1.1. Market Overview

1.2. Market Definition

1.3. Scope of the study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. Research methodology

2.1. Research Design

2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter's Five Forces Analysis

4.5.1. Bargaining Power of Suppliers

4.5.2. Bargaining Power of Buyers

4.5.3. Threat of New Entrants

4.5.4. Threat of Substitutes

4.5.5. Competitive Rivalry in the Industry

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. Prenatal Testing Market by Technique

5.1. Non-invasive

5.1.1. Sonography

5.1.2. Biochemical Screening Tests

5.1.3. Cell-Free DNA Screening Tests

5.2. Invasive

5.2.1. Amniocentesis

5.2.2. Chorionic Villus Sampling (CVS)

6. Prenatal Testing Market by Indication

6.1. Genetic Diseases

6.2. Infectious Diseases

7. Prenatal Testing Market by End-Users

7.1. Hospitals and Clinics

7.2. Diagnostic Labs

8. Prenatal Testing Market by Geography

8.1. North America

8.1.1. USA

8.1.2. Canada

8.1.3. Mexico

8.2. South America

8.2.1. Brazil

8.2.2. Argentina

8.2.3. Others

8.3. Europe

8.3.1. UK

8.3.2. Germany

8.3.3. Italy

8.3.4. Spain

8.3.5. Others

8.4. Middle East and Africa

8.4.1. Israel

8.4.2. Saudi Arabia

8.4.3. Others

8.5. Asia Pacific

8.5.1. China

8.5.2. Japan

8.5.3. India

8.5.4. Australia

8.5.5. Others

9. Competitive intelligence

9.1. Competitive Benchmarking and Analysis

9.2. Strategies of Key Players

9.3. Recent Investments and Deals

10. Company Profile

10.1. Agilent Technologies, Inc.

10.2. Invitae Corporation

10.3. Illumina, Inc.

10.4. Laboratory Corporation of America Holdings

10.5. Natera, Inc.

10.6. Quest Diagnostics Incorporated

10.7. F. Hoffmann-La Roche Ltd

10.8. Sequenom Laboratories

10.9. BGI Diagnosis Co., Ltd

10.10. IGENOMIX S.L.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900